Investec Bank Plc has filed a formal dealing disclosure relating to Advanced Medical Solutions Group Plc, as required under Rule 8.5 of the Takeover Code.
The disclosure was filed under Form 8.5 as a public dealing notice by an exempt principal trader operating with recognised intermediary status in a client-serving capacity.
Investec Bank Plc is identified in the filing as both Advisor and Joint Broker to Advanced Medical Solutions Group Plc, establishing its connected status to the offer.
The dealings were undertaken on 12th October 2026, with the disclosure formally dated 13th October 2026, in line with regulatory requirements.
In terms of transactions involving ordinary shares, Investec purchased a total of 16,108 shares at a price of 282.25 pence per unit during the dealing period.
The firm also recorded sales of 141 ordinary shares, also transacted at a price of 282.25 pence per unit on the same date.
No cash-settled derivative transactions were reported as part of this disclosure, with those sections of the form returning not applicable designations.
Similarly, no stock-settled derivative transactions, including options of any kind, were reported as part of the filing for this period.
Investec confirmed there are no indemnity or other dealing arrangements in place that could constitute an inducement to deal or refrain from dealing with any party to the offer.
The firm also confirmed no agreements, arrangements, or understandings exist relating to voting rights or future acquisition or disposal of relevant securities tied to any derivative.
The contact named in the disclosure is Priyali Bhattacharjee, and public disclosures under Rule 8 of the Takeover Code are required to be made to a Regulatory Information Service.
The Panel’s Market Surveillance Unit remains available for consultation regarding the Code’s dealing disclosure requirements, providing ongoing oversight of market activity during offer periods.
